NCT05771519Not yet recruiting
Developing an HIV Disclosure Intervention for Men in Uganda
Development and Assessment of an HIV Disclosure Intervention for Men in Uganda
Source: ClinicalTrials.gov · Last updated 16 Jul 2026
Brief summary (registry, in English)
The goal of this clinical trial is to test an HIV disclosure intervention that the investigators are developing focused on men living with HIV in Uganda. The main questions the investigators are trying to answer is whether the HIV disclosure intervention the investigators develop will help men who receive this intervention to disclose their HIV status to a greater extent than men who receive standard care. Participants assigned to the intervention group will likely participate in the following: * Sexual health education * Cognitive behavioral therapy strategies * Problem-solving skills building * Motivational interviewing * Developing a personalized HIV disclosure plan * Communication skills building * Role-playing disclosure strategies
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 6 Mar 2023
- Start date
- Sept 2026
- Primary completion date
- Jul 2027
- Lead sponsor
- Brigham and Women's Hospital
- Diseases
- HIV
- NCT number
- NCT05771519
What you commit to
- Study type: Interventional
- Planned participants: 70
- From Sept 2026 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- an inability to speak the local language (Runyankole) or English
- an inability to provide informed consent
Criteria the registry did not label
- For all 3 Aims, "index participants" inclusion criteria will include:
- men living with HIV
- with sexually transmitted infection symptoms (e.g., urethral discharge, genital lesions)
- either not accessing antiretroviral therapy (per self-report109 and/or clinic documentation) or accessing antiretroviral therapy without HIV viral suppression
- age ≥18 years,
- with at least one sexual partner in the past three months
- Aims 2 and 3 have the additional inclusion criteria:
- men living with HIV without HIV disclosure to at least one partner.
- In Aims 2 and 3, male participants will be encouraged to invite sexual partners for enrollment. These "partner participants" will have the following inclusion criteria:
- age ≥18 years
- partnered with an enrolled man who reports HIV disclosure or plans for HIV disclosure with study support
- referred by the male participant.
Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mbarara University of Science and Technology Coordinator of this site? Confirm its status | Mbarara | Uganda | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.